• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 vaccination in Israel.

作者信息

Muhsen Khitam, Cohen Dani

机构信息

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Clin Microbiol Infect. 2021 Nov;27(11):1570-1574. doi: 10.1016/j.cmi.2021.07.041. Epub 2021 Aug 9.

DOI:10.1016/j.cmi.2021.07.041
PMID:34384875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8351306/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac50/8351306/6e06e016c1ce/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac50/8351306/5e5a2c661f03/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac50/8351306/6e06e016c1ce/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac50/8351306/5e5a2c661f03/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac50/8351306/6e06e016c1ce/gr2_lrg.jpg

相似文献

1
COVID-19 vaccination in Israel.以色列的新冠疫苗接种情况。
Clin Microbiol Infect. 2021 Nov;27(11):1570-1574. doi: 10.1016/j.cmi.2021.07.041. Epub 2021 Aug 9.
2
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.新冠病毒疫苗接种后和 SARS-CoV-2 阳性检测后的血小板减少症和血栓栓塞风险：自身对照病例系列研究。
BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
3
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.辉瑞-生物科技疫苗和牛津-阿斯利康疫苗对英格兰老年人新冠病毒相关症状、住院及死亡率的有效性：检测阴性病例对照研究
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.
4
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.安全性、免疫原性和异源加强用 SARS-CoV-2 mRNA 疫苗（SYS6006）在中国 18 岁及以上人群中的效果：一项随机、开放标签、阳性对照的 3 期临床试验。
Emerg Microbes Infect. 2024 Dec;13(1):2320913. doi: 10.1080/22221751.2024.2320913. Epub 2024 Feb 29.
5
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
6
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间，mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
7
Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach.mRNA 和腺病毒载体 COVID-19 疫苗的比较安全性分析：使用模拟目标试验方法的全国性队列研究。
Clin Microbiol Infect. 2024 May;30(5):646-652. doi: 10.1016/j.cmi.2023.12.010. Epub 2023 Dec 13.
8
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.mRNA 新冠疫苗 2 剂接种对免疫功能低下成人因 COVID-19 住院的效果-9 个州，2021 年 1 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1553-1559. doi: 10.15585/mmwr.mm7044e3.
9
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
10
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.辉瑞-生物科技和莫德纳疫苗对美国成年人因 COVID-19 住院的持续有效性-2021 年 3 月至 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1156-1162. doi: 10.15585/mmwr.mm7034e2.

引用本文的文献

1
Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population.开发并验证一份针对文化定制的问卷，以评估以色列极端正统犹太人群体中对新冠疫苗的犹豫态度。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429233. doi: 10.1080/21645515.2024.2429233. Epub 2024 Dec 5.
2
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic.COVID-19 疫苗安全技术（VaST）工作组：在大流行期间加强疫苗安全监测。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125549. doi: 10.1016/j.vaccine.2023.12.059. Epub 2024 Feb 9.
3

本文引用的文献

1
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.BNT162b2 疫苗接种与孕妇感染 SARS-CoV-2 的关联。
JAMA. 2021 Aug 24;326(8):728-735. doi: 10.1001/jama.2021.11035.
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
3
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
Review of Israel's action and response during the COVID-19 pandemic and tabletop exercise for the evaluation of readiness and resilience-lessons learned 2020-2021.
回顾以色列在 COVID-19 大流行期间的行动和反应，以及评估准备情况和恢复能力的桌面演习：2020-2021 年的经验教训。
Front Public Health. 2024 Jan 24;11:1308267. doi: 10.3389/fpubh.2023.1308267. eCollection 2023.
4
Trends in the Incidence of Cardiovascular Diagnoses and Procedures over the Years 2012-2021 in Israel: The Impact of the COVID-19 Pandemic.2012年至2021年以色列心血管疾病诊断和治疗发生率的趋势：COVID-19大流行的影响
J Clin Med. 2024 Jan 15;13(2):476. doi: 10.3390/jcm13020476.
5
Encouraging COVID-19 vaccination by focusing on anticipated affect: A scoping review.通过关注预期影响来鼓励新冠病毒疫苗接种：一项范围综述
Heliyon. 2023 Nov 18;9(12):e22655. doi: 10.1016/j.heliyon.2023.e22655. eCollection 2023 Dec.
6
Psychological distress during the COVID-19 pandemic: An integrative perspective.COVID-19 大流行期间的心理困扰：综合观点。
PLoS One. 2023 Oct 26;18(10):e0293189. doi: 10.1371/journal.pone.0293189. eCollection 2023.
7
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.大流行第一年从 COVID-19 中康复的个体中与预奥密克戎和奥密克戎变异株再感染相关的预测因素。
Int J Infect Dis. 2023 Jul;132:72-79. doi: 10.1016/j.ijid.2023.04.395. Epub 2023 Apr 16.
8
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.实体瘤癌症患者对 SARS-CoV-2 疫苗体液免疫反应的决定因素：系统评价和荟萃分析。
Vaccine. 2023 Mar 10;41(11):1791-1798. doi: 10.1016/j.vaccine.2023.01.072. Epub 2023 Feb 13.
9
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East.父母对子女 COVID-19 疫苗的健康信念、意愿和策略：来自中东五个阿拉伯国家的横断面分析。
Vaccine. 2022 Oct 26;40(45):6549-6557. doi: 10.1016/j.vaccine.2022.09.052. Epub 2022 Sep 23.
10
Community engagement to support COVID-19 vaccine uptake: a living systematic review protocol.社区参与支持 COVID-19 疫苗接种：一项正在进行的系统评价方案。
BMJ Open. 2022 Sep 20;12(9):e063057. doi: 10.1136/bmjopen-2022-063057.
mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
4
A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021.2020年2月至2021年2月以色列新冠疫情中人群组差异的全国性分析。
Lancet Reg Health Eur. 2021 Aug;7:100130. doi: 10.1016/j.lanepe.2021.100130. Epub 2021 Jun 5.
5
Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.接种 BNT162b2 疫苗 13 至 24 天后对 SARS-CoV-2 感染有效性的评估。
JAMA Netw Open. 2021 Jun 1;4(6):e2115985. doi: 10.1001/jamanetworkopen.2021.15985.
6
Myocarditis following COVID-19 mRNA vaccination.新冠病毒mRNA疫苗接种后的心肌炎
Vaccine. 2021 Jun 29;39(29):3790-3793. doi: 10.1016/j.vaccine.2021.05.087. Epub 2021 May 28.
7
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine.青少年接种 BNT162b2 mRNA COVID-19 疫苗后的短暂性心脏损伤。
Pediatr Infect Dis J. 2021 Oct 1;40(10):e360-e363. doi: 10.1097/INF.0000000000003235.
8
[THE NEED FOR REDUCING DISPARITIES IN SARS-COV-2 IMMUNIZATION: THE ULTRAORTHODOX AND ARAB POPULATIONS IN ISRAEL].[减少新冠病毒免疫接种差距的必要性：以色列的极端正统派和阿拉伯人群]
Harefuah. 2021 May;160(5):285-290.
9
The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.两剂 BNT162b2 疫苗的有效性：真实世界数据分析。
Clin Infect Dis. 2022 Feb 11;74(3):472-478. doi: 10.1093/cid/ciab438.
10
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后，mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果：一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.